Evidence map›Paper›PMID 39298496›Full record

ArticlePloS one2024

A retrospective characterization of pediatric facemasks marketed in the United States and implications for future designs.

Ali Hasani, Bryan Ibarra, Kirstie Snodderly, Dana Rottach, BiFeng Qian, Daniel Porter, Suvajyoti Guha

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ali HasaniDivision of Applied Mechanics, Office of Science and Engineering Laboratories, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Bryan IbarraDivision of Applied Mechanics, Office of Science and Engineering Laboratories, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Kirstie SnodderlyOffice of the Chief Scientist, Office of Commissioner, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Dana RottachOffice of Product Evaluation and Quality, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.ORCID 0000-0003-0459-5980
BiFeng QianOffice of Product Evaluation and Quality, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Daniel PorterDivision of Applied Mechanics, Office of Science and Engineering Laboratories, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Suvajyoti GuhaDivision of Applied Mechanics, Office of Science and Engineering Laboratories, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.ORCID 0000-0002-7622-2721

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDevice manufacturers who seek to market their pediatric facemasks in the United States (U.S.), as part of anthropometric data requirement, need to demonstrate their mask designs are expected to fit the intended user population. However, currently there are no well accepted test methodologies for pediatric facemasks. In addition, unlike N95 respirators, the expected maximum flow rate, and the pressure drop at that expected maximum flow rate for pediatric facemasks have not been established.

methodThe objective of this article is three-fold; use a literature survey to determine the worst-case flow rate, and an acceptable breathing resistance; and come up with a bench-test based protocol for assessing fit of pediatric facemasks. RESULTS & DISCUSSION: The worst-case breathing flow rate for mask testing in the pediatric population is 45-60 Liters/minute (LPM), and the acceptable pressure drop at the worst-case flow rate is 2.0 mmH2O. A retrospective assessment of all the four brands of legally marketed facemasks in the U.S. that could be purchased, revealed that majority of the brands have high filtration efficiency (>95%) at low flow rate 5 LPM which reduces to ~ 80% at 45 LPM. At 5 LPM, the pressure drop ranges from 0.3-0.6 mmH2O, remaining below the 2.0 mmH2O. However, at higher flow rates, (representing strenuous activities, or older children (> 12 years)), most masks exhibited a pressure drop within the range of 2.9 to 6.0 mmH2O. Furthermore, opening the pleats of the facemasks completely results in a notable reduction in pressure drop (a 6.6-fold decrease, p = 0.03). To assess fit of these same brands of facemasks, we then updated our previous validated adult manikin fit-test method and used it in manikins in the age group of 2 to 14 years. Either poor nose-clip adherence to the manikin, low filtration efficiency of the pediatric facemasks, or off-label use (i.e. when donned on manikins representing 2 years to 14 years) contributed to low fit.

conclusionsA new bench-top tool to evaluate quantitative fit of pediatric facemasks was developed. In addition, based on the research reported here, we provide practical implications for the members of the community: users, academia and medical device manufacturers.

Indexed as

Equipment DesignMasksPediatricsAdolescentChildChild, PreschoolHumansRespiratory MechanicsRetrospective Studies

Identifiers

PMID39298496
PMCPMC11412539

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.